Linkage and association of proinflammatory cytokines genes IL-6, IFNG and TNF with multiple sclerosis

Molecular Biology

Volumn 44, Issue 5, 2010, Pages 728-733

  Makarycheva, O Yu ^a   Tsareva, E Yu ^a,b   Sudomoina, M A ^a,b   Kulakova, O G ^a,b   Bykova, O V ^c   Gol'tsova, N V ^c   Kuzenkova, L M ^c   Boiko, A N ^b   Favorova, O O ^a,b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

allelic polymorphism; functional genomics; genotyping; human; IFNG; IL 6; inter leukin 6; interferon ; multiple sclerosis; proinflammatory cytokines; TDT; TNF; tumor necrosis factor

Indexed keywords

EID: 77957975518     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893310050079     Document Type: Article

References (48)

1. Dyment D. A., Ebers G. C., Sadovnick A. D. 2004. Genetics of multiple sclerosis. Lancet Neurol. 3, 104-110.
2. Zhang H., Zhao H., Merikangas K. 1997. Strategies to identify genes for complex diseases. Ann. Med. 29, 493-498.
3. Favorova O. O., Kulakova O. G., Boiko A. N. 2010. Multiple sclerosis as a polygenic disease: An update. Genetika. 46, 302-313.
4. Risch N. J. 2000. Searching for genetic determinants in the new millennium. Nature. 405, 847-856.
5. Hattersley A. T., McCarthy M. I. 2005. What makes a good genetic association study? Lancet. 366, 1315-1323.
6. Spielman R. S., Ewens W. J. 1996. The TDT and other family-based tests for linkage disequilibrium and association. Am. J. Hum. Genet. 59, 983-989.
7. Spielman R. S., McGinnis R. E., Ewens W. J. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506-516.
8. Marrosu M. G., Murru R., Costa G., Melis M. C., Rolesu M., Schirru L., Solla E., Cuccu S., Secci M. A., Whalen M. B., Cocco E., Pugliatti M., Sotgiu S., Rosati G., Cucca F. 2007. Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet. 8, 25.
9. Couturier N., Gourraud P. A., Cournu-Rebeix I., Gout C., Bucciarelli F., Edan G., Babron M. C., Clerget-Darpoux F., Clanet M., Fontaine B., Brassat D. 2009. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. Eur. J. Hum. Genet. 17, 844-847.
10. D'Alfonso S., Bolognesi E., Guerini F. R., Barizzone N., Bocca S., Ferrante D., Castelli L., Bergamaschi L., Agliardi C., Ferrante P., Naldi P., Leone M., Caputo D., Ballerini C., Salvetti M., Galimberti D., Massacesi L., Trojano M., Momigliano-Richiardi P. 2008. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. Genes Immun. 9, 7-15.
11. Hafler D. A., Compston A., Sawcer S., Lander E. S., Daly M. J., De Jager P. L., de Bakker P. I., Gabriel S. B., Mirel D. B., Ivinson A. J., Pericak-Vance M. A., Gregory S. G., Rioux J. D., McCauley J. L., Haines J. L., Barcellos L. F., Cree B., Oksenberg J. R., Hauser S. L. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862.
12. Chao M. J., Barnardo M. C., Lui G. Z., Lincoln M. R., Ramagopalan S. V., Herrera B. M., Dyment D. A., Sadovnick A. D., Ebers G. C. 2007. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: Accounting for linkage disequilibrium. Hum. Mol. Genet. 16, 1951-1958.
13. Boiko A. N., Gusev E. I., Sudomoina M. A., Alekseenkov A. D., Kulakova O. G., Bikova O. V., Maslova O. I., Guseva M. R., Boiko S. Y., Guseva M. E., Favorova O. O. 2002. Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology. 58, 658-660.
14. Willer C. J., Dyment D. A., Cherny S., Ramagopalan S. V., Herrera B. M., Morrison K. M., Sadovnick A. D., Risch N. J., Ebers G. C. 2007. A genome-wide scan in forty large pedigrees with multiple sclerosis. J. Hum. Genet. 52, 955-962.
15. Giedraitis V., Modin H., Callander M., Landtblom A. M., Fossdal R., Stefansson K., Hillert J., Gulcher J. 2003. Genome-wide TDT analysis in a localized population with a high prevalence of multiple sclerosis indicates the importance of a region on chromosome 14q. Genes Immun. 4, 559-563.
16. Wheeler R. D., Owens T. 2005. The changing face of cytokines in the brain: Perspectives from EAE. Curr. Pharm. Des. 11, 1031-1037.
17. McFarland H. F., Martin R. 2007. Multiple sclerosis: A complicated picture of autoimmunity. Nature Immunol. 8, 913-919.
18. Holmoy T., Hestvik A. L. 2008. Multiple sclerosis: Immunopathogenesis and controversies in defining the cause. Curr. Opin. Infect. Dis. 21, 271-278.
19. Kreutzberg G. W. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
20. Acosta-Rodriguez E. V., Napolitani G., Lanzavecchia A., Sallusto F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nature Immunol. 8, 942-949.
21. El-Behi M., Rostami A., Ciric B. 2010. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5, 189-197.
22. Wilson A. G., Symons J. A., McDowell T. L., McDevitt H. O., Duff G. W. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA. 94, 3195-3199.
23. Pravica V., Perrey C., Stevens A., Lee J. H., Hutchinson I. V. 2000. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 61, 863-866.
24. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P. 1998. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369-1376.
25. McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H. P., Lublin F. D., McFarland H. F., Paty D. W., Polman C. H., Reingold S. C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B. Y., Wolinsky J. S. 2001. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127.
26. Sambrook J., Fritsch E. F., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press, vol. 9, pp. 17-19.
27. He B., Navikas V., Lundahl J., Soderstrom M., Hillert J. 1995. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63, 143-147.
28. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P. J., Hutchinson I. V. 1999. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur. J. Immunogenet. 26, 1-3.
29. DeMichele A., Martin A. M., Mick R., Gor P., Wray L., Klein-Cabral M., Athanasiadis G., Colligan T., Stadtmauer E., Weber B. 2003. Interleukin-6 -174G-> C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 63, 8051-8056.
30. Purcell S., Sham P., Daly M. J. 2005. Parental phenotypes in family-based association analysis. Am. J. Hum. Genet. 76, 249-259.
31. Favorova O. O., Favorov A. V., Boiko A. N., Andreewski T. V., Sudomoina M. A., Alekseenkov A. D., Kulakova O. G., Gusev E. I., Parmigiani G., Ochs M. F. 2006. Three allele combinations associated with multiple sclerosis. BMC Med. Genet. 7, 63.
32. Konenkov V. I., Golovanova O. V., Dortman V. V., Shevchenko A. V., Karpova A. V. 2008. TNFA gene poly-morphism and linkage disequilibrium between TNFA and HLA class II genes (DRB1, DQA1, DQB1) in the Siberian Caucasoid population. Immunologiya. 29, 6-10.
33. Burmistrova A. L., Stashkevich D. A., Suslova T. A., Khromova E. B., Isakanova A. O., Devald I. V. 2007. Tumor necrosis factor gene polymorphism in patients with rheumatoid arthritis from the Russian population of the Chelyabinsk region. Usp. Sovrem. Estestvozn. 12, 134-137.
34. Ristic S., Lovrecic L., Starcevic-Cizmarevic N., Brajenovic-Milic B., Sega Jazbec S., Sepcic J., Kapovic M., Peterlin B. 2007. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients. Eur. Neurol. 57, 203-207.
35. Drulovic J., Popadic D., Mesaros S., Dujmovic I., Cvetkovic I., Miljkovic D., Stojsavljevic N., Pravica V., Pekmezovic T., Bogdanovic G., Jarebinski M., Mostarica Stojkovic M. 2003. Decreased frequency of the tumor necrosis factor alpha-308 allele in Serbian patients with multiple sclerosis. Eur. Neurol. 50, 25-29.
36. Mycko M., Kowalski W., Kwinkowski M., Buenafe A. C., Szymanska B., Tronczynska E., Plucienniczak A., Selmaj K. 1998. Multiple sclerosis: The frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J. Neuroimmunol. 84, 198-206.
37. Danilko K. V., Korytyna G. F., Akhmadishina L. Z., Yanbaeva D. G., Zagidullin Sh. Z., Victorova T. V. 2007. Association of polymorphisms of cytokine genes (IL1B, IL1RN, TNFA, LTA, IL-6, IL8, and IL10) with chronic obstructive pulmonary disease. Mol. Biol. 41, 22-31.
38. Matos G. I., Covas Cde J., Bittar Rde C., Gomes-Silva A., Marques F., Maniero V. C., Amato V. S., Oliveira-Neto M. P., Mattos Mda S., Pirmez C., Sampaio E. P., Moraes M. O., Da-Cruz A. M. 2007. IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production. BMC Infect Dis. 7, 33.
39. Pertovaara M., Antonen J., Hurme M. 2006. Th2 cytokine genotypes are associated with a milder form of primary Sjogren's syndrome. Ann. Rheum. Dis. 65, 666-670.
40. Risch N., Teng J. 1998. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases: 1. DNA pooling. Genome Res. 8, 1273-1288.
41. Kamali-Sarvestani E., Nikseresht A., Aflaki E., Sarvari J., Gharesi-Fard B. 2007. TNF-alpha, TNF-beta and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis. Acta Neurol. Scand. 115, 161-166.
42. Dong Y. X., Xu Z. R., Lin P. Y. 2006. Association among serous and cerebrospinal fluid TNF-alpha level, gene polymorphisms of TNF-alpha and multiple sclerosis in Han nationality of southern China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 23, 677-679.
43. Mihailova S., Ivanova M., Mihaylova A., Quin L., Mikova O., Naumova E. 2005. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J. Neuroimmunol. 168, 138-143.
44. Sarial S., Shokrgozar M. A., Amirzargar A., Shokri F., Radfar J., Zohrevand P., Arjang Z., Sahraian M. A., Lotfi J. 2008. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis. Iran J. Allergy Asthma Immunol. 7, 37-40.
45. Fedetz M., Matesanz F., Pascual M., Martin J., Fernandez O., Guerrero M., Alcina A. 2001. The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis. J. Neurol. Sci. 190, 69-72.
46. Amirzargar A., Khosravi F., Dianat S., Hushmand F., Maryousef P., Foroushani A. R., Lotfi J., Nikbin B. 2007. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients. Mult. Scler. 13, 253-255.
47. Wansen K., Pastinen T., Kuokkanen S., Wikstrom J., Palo J., Peltonen L., Tienari P. J. 1997. Immune system genes in multiple sclerosis: Genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1ra/IL-1 beta loci. J. Neuroimmunol. 79, 29-36.
48. Shokrgozar M. A., Sarial S., Amirzargar A., Shokri F., Rezaei N., Arjang Z., Radfar J., Yousefi-Behzadi M., Ali Sahraian M., Lotfi J. 2009. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J. Clin. Immunol. 29, 747-751.